Pre-steady-state Kinetic Studies Establish Entecavir 5′-Triphosphate as a Substrate for HIV-1 Reverse Transcriptase

This publication has 23 references indexed in Scilit:

• Activity against Human Immunodeficiency Virus Type 1, Intracellular Metabolism, and Effects on Human DNA Polymerases of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine
  Antimicrobial Agents and Chemotherapy, 2007
• The HBV Drug Entecavir — Effects on HIV-1 Replication and Resistance
  New England Journal of Medicine, 2007
• Inhibition of Hepatitis B Virus Polymerase by Entecavir
  Journal of Virology, 2007
• Entecavir: A new neucleoside analogue for the treatment of chronic hepatitis B
  Drugs of Today, 2007
• Mechanism of action of a novel viral mutagenic covert nucleotide: molecular interactions with HIV-1 reverse transcriptase and host cell DNA polymerases
  Antiviral Research, 2005
• Fixed Conformation Nucleoside Analogs Effectively Inhibit Excision-proficient HIV-1 Reverse Transcriptases
  Journal of Molecular Biology, 2005
• UCSF Chimera—A visualization system for exploratory research and analysis
  Journal of Computational Chemistry, 2004
• The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance
  Journal of Clinical Investigation, 2001
• Pre-Steady-State Kinetic Characterization of Wild Type and 3‘-Azido-3‘-deoxythymidine (AZT) Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Implication of RNA Directed DNA Polymerization in the Mechanism of AZT Resistance
  Biochemistry, 1997
• Selective action of 4'-azidothymidine triphosphate on reverse transcriptase of human immunodeficiency virus type 1 and human DNA polymerases .alpha. and .beta.
  Biochemistry, 1993